Japan Medical Dynamic Marketing 7600.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 7600.T. It has been listed since 24 March 2000. In the fiscal year to 31 March 2026, it reported revenue of ¥23.92bn and net income of ¥263.1m. At that date it held total assets of ¥35.68bn and shareholders' equity of ¥25.40bn.

Japan Medical Dynamic Marketing, Inc. engages in the development, manufacture, import and sale of medical equipment. The company is headquartered in Shinjuku, Tokyo-To. The company went IPO on 2000-03-24. The firm is principally engaged in the import, development, manufacture and sale of medical equipment primarily in the field of orthopedic surgery. The firm has two segments. The Japan segment imports materials for osteosynthesis, artificial joints and spinal fixation devices from manufacturers, and sell them in Japan. The America segment is involved in the development and manufacture of materials for osteosynthesis, artificial joints, spinal fixation devices and other products, as well as the sale of medical equipment in North America. As of March 31, 2014, the Company had one subsidiary in the United States.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Toshiyuki HironakaPresident, Executive President, Representative Director, since 2009
• Mr. Brent BartholomewPresident of Subsidiary, Director, since 2021
• Mr. Yasuaki HidakaSenior Executive Officer, Deputy Chief Director of Sales, Director, since 2020
• Mr. Katsuhiko SeshitaSenior Executive Officer, Chief Director of Sales, since 2007
• Mr. Koichi KondoSenior Executive Officer, Chief Director of Marketing, since 2007
• Mr. Shinichi MiyataExecutive Officer, Chief Director of Pharmaceutical Affairs & Development
• Mr. Naoto SawakiExecutive Officer, Chief Director of Administration, Chief Director of SCM, since 2016
• Mr. Yusuke YoshidaExecutive Officer, Chief Director of Business Strategy
• Mr. Hiroshi IshikawaIndependent Director
• Mr. Tomoyuki OkamuraIndependent Director
• Mr. Toshio SaburiIndependent Director
• Mr. Shinji MunechikaManager of IR Office, since 2022

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.